Background: The mechanism behind the association between human leukocyte antigen (HLA) molecules and the rate of HIV-1\ud disease progression is still poorly understood. Recent data suggest that ‘‘protective’’ HLA molecules, i.e. those associated with\ud a low HIV-1 viral load and relatively slow disease progression, tend to present epitopes from the Gag capsid protein. Although\ud this suggests that preferential targeting of Gag delays disease progression, the apparent preference for Gag could also be\ud a side-effect of the relatively high immunogenicity of the protein. Methods and Findings: To separate cause and effect, we\ud predicted HIV-1 epitopes from the whole genome of HIV-1, and found that protective HLA alleles have a true preference for the\ud p24 Gag protein, while non-protective HLA alleles preferentially target HIV-1 Nef. In line with this, we found a significant\ud negative correlation between the predicted affinity of the best-binding p24 epitopes and the relative hazard of HIV-1 disease\ud progression for a large number of HLA molecules. When the epitopes targeted by protective HLA alleles were mapped to the\ud known p24 structure, we found that mutations in these epitopes are likely to disturb the p24 dimer structure, which is\ud expected to severely reduce the fitness of the virus. Conclusions: Our results suggest that the intrinsic preference of different\ud HLA molecules to present p24 peptides explains why some HLA molecules are more protective than others
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.